CUV 2.80% $13.19 clinuvel pharmaceuticals limited

volume in europe, a precursor?, page-4

  1. 3,045 Posts.
    I think CUV will do very well indeed if they get approval in the EU... first, let's see some good final results. Then cross your fingers... I can just imagine all those back of the envelope calculations coming back.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.